Expertise

The people and platform
behind the model.

Every Clinrova COL is a senior clinical professional with a minimum of 10 years of experience, matched to your therapeutic area and investigative ecosystem. They are supported by an AI platform that aggregates real-time data from every system your trial runs on.

Therapeutic Areas

Therapeutic area focus.

Our primary focus is rare disease. Our COLs are matched to studies based on therapeutic area fit and investigator network familiarity — not geography. The areas below represent where we have the deepest operational experience.

Rare Disease
Small patient populations, concentrated investigator networks, and high-stakes proof-of-concept data. Every enrolled patient is irreplaceable. The COL model's continuity and relationship depth are not optional in this space — they are the baseline requirement for monitoring that actually works.
High-complexity
Neurology & CNS
Managing subjective endpoints, complex rating scales, and extended follow-up periods with rigorous data quality oversight. Ensuring rater reliability and protocol adherence across specialized sites.
Endpoint-sensitive
Cardiovascular & Metabolic
Coordinating high-volume trials, managing extensive safety data, and ensuring endpoint adjudication compliance. Experienced in managing the rigorous safety reporting demands of cardiovascular outcomes trials.
High-volume
Immunology & Rheumatology
Overseeing complex biomarker tracking, specialized central lab coordination, and nuanced safety reporting. Managing the long-term follow-up and immunogenicity assessments common in biologic trials.
Biomarker-intensive
Medical Devices
Understanding the distinct regulatory pathways, device accountability requirements, and specialized site training required for IDE and PMA studies. Experienced in managing the unique operational demands of device trials.
Regulatory-distinct
Infectious Disease & Vaccines
Managing rapid enrollment timelines, complex safety monitoring, and the logistical demands of vaccine and infectious disease trials — including cold chain oversight and specialized sample handling.
Time-critical
Trial Phases

Phase coverage.

Our primary focus is Phase 2. Phase I, Phase III, and post-market studies are evaluated on a case-by-case basis.

Phase I
I
First-in-Human & Dose Escalation
Intensive safety monitoring, rapid dose escalation coordination, and rigorous PK/PD data oversight. The COL maintains constant site vigilance and ensures immediate escalation of any safety signal.
Safety-intensive Rapid escalation
Phase II
II
Proof of Concept & Signal Detection
This is where we are most focused. Rare disease Phase 2 programs require a monitoring model that can handle small patient populations, concentrated investigator networks, and high-stakes go/no-go data. The COL model was built for this environment.
Enrollment focus Signal detection
Phase III
III
Pivotal & Multi-Center Trials
Managing large, multi-center networks with consistent protocol adherence at scale. The COL ensures inspection readiness is maintained throughout — not just at close-out — across every site in the network.
Multi-site scale Inspection-ready
Phase IV
IV
Post-Market & Surveillance
Distributed site oversight for approved products, with ongoing safety signal monitoring, real-world evidence collection, and regulatory reporting support across large, geographically dispersed site networks.
Distributed networks RWE collection
Operational Rigor

What the COL actually
owns at your site.

The COL is not a monitor who reviews data and writes visit reports. They own the full operational picture at every site — including the things that fall through the cracks in a fragmented model.

TMF Management
Continuous, inspection-ready document oversight from start-up through close-out. No scramble at the end.
Vendor Oversight
Direct management of central labs, imaging core labs, and specialty vendors at the site level — handled by the COL, not escalated up a chain.
Budget & Payments
Site budget tracking, invoice validation, and timely investigator payments — all within the COL's operational view.
Inspection Readiness
Proactive compliance management maintained throughout the trial — not a last-minute exercise before an audit.
Protocol Deviation Mgmt
Root cause analysis, CAPA development, and tracking — owned by the COL and reported with full transparency.
Safety Facilitation
PV queries, medical monitor reviews, and AE/SAE reconciliation handled in-line — not deferred to a separate safety team.
COL Operational Coverage
Full-spectrum
TMF completeness
96%
Protocol adherence
98%
Query resolution rate
94%
SAE reporting on time
100%
Vendor issue resolution
92%
What the COL Owns
Site selection & feasibility
Site initiation & activation
Ongoing monitoring & data review
Vendor & lab coordination
Budget tracking & payments
Site close-out & archiving
The COL Standard

Who leads
your sites?

We do not hire junior monitors and train them on your study. A Clinrova COL is a senior clinical professional with a minimum of 10 years of experience, selected for therapeutic area fit and investigator network familiarity. They are matched to your study before you sign anything.

Senior-level experience
Our COLs bring a minimum of 10 years of clinical research experience, with backgrounds spanning site coordination, CRA monitoring, and clinical trial management. They have seen what goes wrong — and know how to prevent it.
Broad operational fluency
Fluency across EDC, CTMS, TMF, and safety systems — combined with the ability to manage vendors, budgets, and investigator relationships without escalation. The COL is the single point of contact for everything at the site.
Investigator-grade relationships
Proven ability to build and maintain deep, peer-to-peer relationships with principal investigators and study coordinators. Sites perform better when they trust and respect the person overseeing them.
Continuity protected by design
We don't promise that people never leave — we promise that continuity is never at risk. Every study is overseen by a Director of Clinical Operations who maintains intimate, real-time knowledge of every site and its performance. If a COL ever needs to transition, the DCO steps in with full context — no learning curve, no gap, no disruption to your trial.
The Clinrova COL
Not a monitor.
A clinical leader —
backed by a director.
10+
Years clinical research experience
1
COL per site — no exceptions
100%
Site ownership, start to close-out
DCO
Director-level oversight on every study
EDC fluency TMF management Vendor oversight Budget tracking Safety facilitation CTMS RTSM Protocol deviation mgmt

Tell us about
your study.

Schedule a Conversation